Skip to content

Clinical trials

Phase 2 Burkitt Lymphoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Phase 2 Country / region: Spain Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20141
20151
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
PETHEMA Foundation2
Amgen Research (Munich) GmbH1
Kite, A Gilead Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma7
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Neoplasm, Residual2
Leukemia1
Leukemia, Hairy Cell1
Lymphatic Diseases1
Lymphoma, B-Cell1
Lymphoma, Follicular1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.